TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-22
DOI
10.1038/s41598-017-10124-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement Regulatory Protein CD46 Protects against Choroidal Neovascularization in Mice
- (2014) Valeriy Lyzogubov et al. AMERICAN JOURNAL OF PATHOLOGY
- IKK2 Inhibition Attenuates Laser-Induced Choroidal Neovascularization
- (2014) Huayi Lu et al. PLoS One
- The relationship between intervention in the CD40 signal pathway and choroidal neovascularization
- (2014) Fang Liu et al. OncoTargets and Therapy
- TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A
- (2014) X Shi et al. Cell Death & Disease
- The regulation of TGF-β/SMAD signaling by protein deubiquitination
- (2014) Juan Zhang et al. Protein & Cell
- Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization
- (2013) Irina Semkova et al. EXPERIMENTAL EYE RESEARCH
- An update on the pharmacotherapy of neovascular age-related macular degeneration
- (2013) K Bailey Freund et al. EXPERT OPINION ON PHARMACOTHERAPY
- LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
- (2013) Xiaomeng Wang et al. NATURE
- Transforming Growth Factor-Beta Inhibition Reduces Progression of Early Choroidal Neovascularization Lesions in Rats: P17 and P144 Peptides
- (2013) Javier Zarranz-Ventura et al. PLoS One
- Topical Application of PPADS Inhibits Complement Activation and Choroidal Neovascularization in a Model of Age-Related Macular Degeneration
- (2013) Kerstin Birke et al. PLoS One
- Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy
- (2012) Sirpa Loukovaara et al. ACTA OPHTHALMOLOGICA
- TGF-β signalling and its role in cancer progression and metastasis
- (2012) Yvette Drabsch et al. CANCER AND METASTASIS REVIEWS
- Management of retinal vascular diseases: a patient-centric approach
- (2012) C S Brand EYE
- Suppression of Experimental Choroidal Neovascularization by Curcumin in Mice
- (2012) Ping Xie et al. PLoS One
- The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)
- (2011) Khaled Nassar et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
- (2011) Pearse A. Keane et al. Journal of Ophthalmology
- Laser Photocoagulation, Photodynamic Therapy, and Intravitreal Bevacizumab for the Treatment of Juxtafoveal Choroidal Neovascularization Secondary to Pathologic Myopia
- (2010) Maurizio Battaglia Parodi ARCHIVES OF OPHTHALMOLOGY
- Transforming Growth Factor type β and Smad family signaling in stem cell function
- (2009) Eve Seuntjens et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Transforming growth factor-beta 1 (TGF-β1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis
- (2009) Giovanni Ferrari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Self-Reported Age-Related Eye Diseases and Visual Impairment in the United States: Results of the 2002 National Health Interview Survey
- (2008) Asel Ryskulova et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-β in Vascular Morphogenesis
- (2008) Matthew T. Holderfield et al. CIRCULATION RESEARCH
- Complications in patients after intravitreal injection of bevacizumab
- (2007) Chiharu Shima et al. ACTA OPHTHALMOLOGICA
- Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
- (2007) Lorea Bueno et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search